Patents by Inventor Andreas Roidl

Andreas Roidl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs
    Publication number: 20100143386
    Abstract: The present invention relates to Fibroblast-Growth Factor Receptor 4 (FGRF4) inhibitors for co-administration with a therapeutic procedure or/and agent for the prevention, alleviation or/and treatment of a hyperproliferative disorder, e.g. cancer, such as chemotherapy resistant cancer. Further, the present invention relates to a diagnostic procedure wherein expression status and/or polymorphisms of the FGFR4 gene are determined in a patient suffering from a hyperproliferative disorder, e.g. cancer. Based on the results of this determination and the status of the disorder to be treated a therapeutic protocol may be developed. Yet another subject of the present invention is a screening method.
    Type: Application
    Filed: November 2, 2007
    Publication date: June 10, 2010
    Applicant: Max-Planck-Gesellschaft zur foerderung der Wissenschaften, e. V.
    Inventors: Axel Ullrich, Hans-Juergen Berger, Andreas Roidl